Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Peripheral biomarkers of endometriosis: A systematic review
When Should I Be Worried About Tap Water that Tastes Bad
5-Amino-1MQ is an unapproved research chemical that inhibits the NNMT enzyme, with neither compound holding UK marketing authorisation
This early symptomatic relief should not be confused with complete recovery but does indicate the peptide is producing biological effects
Disclosure of interest: Shubham Biyani: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.02 - SAH, ANEURYSMS AND VASCULAR MALFORMATIONS P150 - ESOC25-441 MINIMAL GROWTH RISK IN SMALL INCIDENTAL CAROTID OPHTHALMIC ANEURYSMS: REVISITING SURVEILLANCE INTERVALS FOR OPTIMISED MANAGEMENT Ronil Chandra 1,2 , Fergus Taylor 1 , Seana Gall 3,4 , Leon Lai 2,5 , Christopher Photopoulos 1 , Kenny Li 1 , Shreyas Honavar 1 , Lee-Anne Slater 1,6 , Thanh Phan 4,7 1 NeuroInterventional Radiology, Monash Medical Centre, Monash Health, Melbourne, Australia, 2 Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 3 Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 4 Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 5 Neurosurgery, Monash Medical Centre, Monash Health, Melbourne, Australia, 6 Department of Radiology and Radiological Sciences, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 7 Neurology, Monash Medical Centre, Monash Health, Melbourne, Australia Background and Aims: The optimal intervals for radiological surveillance of small incidental carotid ophthalmic artery (CoA) aneurysms remain uncertain, with current guidelines recommending annual or biennial imaging
While small-scale studies are ongoing, the transition to adequately powered trials with comparison groups remains a research priority for advancing regulatory policy and understanding
US$ 28.31
US$ 29.96
US$ 24.17
US$ 24.39
US$ 24.23
US$ 25.81
US$ 24.35
US$ 26.65
US$ 21.12
US$ 29.61
US$ 21.55
US$ 24.95
US$ 29.97